Tumor-infiltrating B cell-related lncRNA crosstalk reveals clinical outcomes and tumor immune microenvironment in ovarian cancer based on single-cell and bulk RNA-sequencing
In conclusion, BCRLss provides a reliable prognostic tool for predicting clinical outcomes and the immune landscape of patients with OC, offering valuable guidance for immunotherapy target selection and personalized treatment strategies.
Authors
- Yue Jiang (ORCID: https://orcid.org/0000-0002-0310-2657)
- Mei Zhang (ORCID: https://orcid.org/0000-0003-3913-181X)
- Muyun Wu
- Qiaoqiao Ding (ORCID: https://orcid.org/0000-0003-0110-8681)
- Zhongxuan Gui
- Mengmeng Zhang
- Yingquan Ye
- Jinping Yang
- Yi Huang (ORCID: https://orcid.org/0009-0009-5862-6923)
Institutions
- Wannan Medical College (CN)
- Anhui Medical University (CN)
- Anhui University of Traditional Chinese Medicine (CN)
- Wuhu Fourth People Hospital (CN)
- Wuhu No 1 People's Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Honghu Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- Heliyon
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e39496
- Citations
- 3
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.86